Senate Finance Committee members from both parties told the CMS on Thursday not to go forward with a Medicare Part B initiative to change how hospitals and doctors are reimbursed for outpatient drugs. (Modern Healthcare)
The proposal, unveiled in March by the Centers for Medicare & Medicaid Services, aims to design incentives for patients and physicians to select lower-cost, high-performing drugs that are administered at medical facilities.(FierceHealthPayer)
The pilot program would reduce the 6 percent add-on to 2.5 percent plus a flat fee of about $16. (The Hill)
For example, a proposed average sales price (ASP) payment reduction in the rule would harm access to “vital drugs” because many providers would face prescription costs that exceed the new Medicare payment amount offered under the model, the Republican lawmakers said.(Bloomberg)
What is Medicare Part B?